iRhythm Holdings, Inc. (IRTC)
NASDAQ: IRTC · Real-Time Price · USD
125.44
-0.52 (-0.41%)
Apr 28, 2026, 4:00 PM EDT - Market closed
iRhythm Holdings Revenue
In the year 2025, iRhythm Holdings had annual revenue of $747.14M with 26.24% growth. iRhythm Holdings had revenue of $208.89M in the quarter ending December 31, 2025, with 27.12% growth.
Revenue (ttm)
$747.14M
Revenue Growth
+26.24%
P/S Ratio
5.48
Revenue / Employee
$311,308
Employees
2,400
Market Cap
4.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 747.14M | 155.30M | 26.24% |
| Dec 31, 2024 | 591.84M | 99.16M | 20.13% |
| Dec 31, 2023 | 492.68M | 81.76M | 19.90% |
| Dec 31, 2022 | 410.92M | 88.10M | 27.29% |
| Dec 31, 2021 | 322.83M | 57.66M | 21.74% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bruker | 3.44B |
| Bio-Rad Laboratories | 2.58B |
| Bio-Rad Laboratories | 2.58B |
| Integer Holdings | 1.85B |
| LivaNova | 1.39B |
| Haemonetics | 1.32B |
| Neogen | 870.56M |
| TransMedics Group | 605.49M |
IRTC News
- 15 hours ago - iRhythm Holdings to Present at the Bank of America Securities 2026 Health Care Conference - GlobeNewsWire
- 1 day ago - New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy - GlobeNewsWire
- 12 days ago - iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026 - GlobeNewsWire
- 19 days ago - Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 4 weeks ago - Data presented at ACC.26 further demonstrate the benefits of iRhythm's Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform - GlobeNewsWire
- 6 weeks ago - iRhythm Holdings Appoints Jason Patten to its Board of Directors - GlobeNewsWire
- 2 months ago - iRhythm Holdings Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire